| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/01/1994 | US5290802 Analgesics, antiinflammatory agents, antiarthritic agents, prostaglandin, enzyme and interleukin inhibitors |
| 03/01/1994 | US5290799 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
| 03/01/1994 | US5290798 Antihistamines, antiallergens, antiinflammatory agents |
| 03/01/1994 | US5290795 Substituted urea compound and use |
| 03/01/1994 | US5290790 Histamine H3 antagonists, psychotropic action |
| 03/01/1994 | US5290788 Antiallergens for mammals |
| 03/01/1994 | US5290780 Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
| 03/01/1994 | US5290763 Ultrafiltration of proteins |
| 03/01/1994 | US5290571 Undenatured whey protein providing Vitamins B1 and B2 |
| 03/01/1994 | US5290561 Patch of room temperature vulcanizable organopolysiloxane rubber, albuterol, diffusion enhancer of normal hydrocarbon alcohol |
| 03/01/1994 | CA2104998A1 Bone-related carboxypeptidase-like protein and process for its production |
| 03/01/1994 | CA2104997A1 Bone-related cadherin-like protein and process for its production |
| 03/01/1994 | CA2104995A1 Bone-related sulfatase-like protein and process for its production |
| 03/01/1994 | CA1327359C Prostaglandin el derivatives as pharmacologically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration |
| 03/01/1994 | CA1327352C Steroid 5-.alpha.-reductase inhibitors |
| 03/01/1994 | CA1327332C Animal derived cell with antigenic protein introduced therein |
| 03/01/1994 | CA1327316C Certain paf antagonist/antihistamine combinations and methods |
| 02/27/1994 | CA2104626A1 Pharmaceutical compounds |
| 02/26/1994 | CA2104764A1 Method for the safe administration of fatty acids |
| 02/26/1994 | CA2104747A1 Method for the safe administration of fatty acids |
| 02/24/1994 | CA2104501A1 Di- and triazinediones |
| 02/23/1994 | EP0584034A2 Cytotoxic drug conjugates for treatment of neoplastic diseases |
| 02/23/1994 | EP0583863A1 Use of esters of L-2-oxothiazolidine-4-carboxylate for the manufacture of a medicament for stimulating intracellar synthesis of glutathione |
| 02/23/1994 | EP0583421A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 02/23/1994 | EP0583378A1 Combined calcium and vitamin d supplements |
| 02/23/1994 | EP0583359A1 Method for treating hypothermia |
| 02/23/1994 | EP0583358A1 Partial liquid breathing of fluorocarbons |
| 02/23/1994 | EP0583346A1 Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase |
| 02/23/1994 | EP0583322A1 Antiserotonines, prepartion thereof and medicaments containing them |
| 02/23/1994 | EP0461111B1 Treatment of osteoporosis |
| 02/23/1994 | CN1082545A Imidazopyridine |
| 02/23/1994 | CN1082543A 吲哚衍生物 Indole derivatives |
| 02/23/1994 | CN1082542A 苯并咪唑衍生物 Benzimidazole derivatives |
| 02/23/1994 | CN1082538A Imidazolyl-substituted cyclohexane derivatives |
| 02/22/1994 | US5288900 Crystallization of optical isomers of leukotriene antagonists using (R)-4-nitro-α-methylbenezenemethonamine |
| 02/22/1994 | US5288878 (1S,2S,3R,5R)-2-[(3S)-2-halo-3-hydroxy-1-alken(ynyl)]-3-trialkylsilyloxy-7,7-(2,2-dimethyl-trimethylenedioxy)bicyclo[3.3.0]octane compounds and processes for their preparation |
| 02/22/1994 | US5288757 Aminosulfonyl urea ACAT inhibitors and a method of lowering blood cholesterol levels therewith |
| 02/22/1994 | US5288751 [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
| 02/22/1994 | US5288749 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 02/22/1994 | US5288748 Centrally acting 6,7,8,9-tetrahydro-3H-benz(e)indole heterocyclics |
| 02/22/1994 | US5288742 α,α dialkylbenzyl derivatives |
| 02/22/1994 | US5288733 Leukotriene synthesis inhibitors |
| 02/22/1994 | US5288730 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 02/22/1994 | US5288704 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent |
| 02/22/1994 | CA2104567A1 Fatty acid treatment |
| 02/22/1994 | CA2104566A1 Fatty acid treatment |
| 02/22/1994 | CA2103943A1 Composition and methods for the generation of bone |
| 02/22/1994 | CA1327204C2 Benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| 02/22/1994 | CA1327200C Urea derivatives |
| 02/22/1994 | CA1327164C Film coated ranitidine hydrochloride tablet |
| 02/21/1994 | CA2101809A1 Cytotoxic drug conjugates for treatment of neoplastic diseases |
| 02/17/1994 | WO1994003644A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | WO1994003600A1 Morphogenic protein soluble complex and composition thereof |
| 02/17/1994 | WO1994003555A1 Antioxidant |
| 02/17/1994 | WO1994003494A1 Conformationally restricted mimetics of reverse turns and peptides containing the same |
| 02/17/1994 | WO1994003482A1 Glycyl-hystidyle-lysine (ghl) derivatives |
| 02/17/1994 | WO1994003481A1 Diamino acid derivatives as antihypertensives |
| 02/17/1994 | WO1994003452A1 Methanesulphonate |
| 02/17/1994 | WO1994003448A1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| 02/17/1994 | WO1994003446A1 4-substituted 1,2,4-triazole derivatives |
| 02/17/1994 | WO1994003444A1 Amide derivatives |
| 02/17/1994 | WO1994003440A1 Benzoxazinones as inhibitors of hiv reverse transcriptase |
| 02/17/1994 | WO1994003437A1 Benzodiazepine derivatives |
| 02/17/1994 | WO1994003430A1 Novel pyridyl- and pyrimidylpiperazine derivatives |
| 02/17/1994 | WO1994003427A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| 02/17/1994 | WO1994003203A1 Alimentary canal cell activator |
| 02/17/1994 | WO1994003201A1 Parathyroid hormone fragments and analogs |
| 02/17/1994 | WO1994003200A1 Morphogen-induced nerve regeneration and repair |
| 02/17/1994 | WO1994003189A1 Therapeutic methods using caesium ions |
| 02/17/1994 | WO1994003179A1 Crystalline amifostine compositions and methods for the preparation and use of same |
| 02/17/1994 | WO1994003178A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 02/17/1994 | WO1994003177A2 Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them |
| 02/17/1994 | WO1994003170A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 02/17/1994 | WO1994003162A1 Medicaments for the treatment or prevention of elevated intraocular pressure |
| 02/17/1994 | WO1994003059A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 02/17/1994 | WO1993025240A3 Pretargeting methods and compounds |
| 02/17/1994 | WO1993020839A3 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality |
| 02/17/1994 | CA2142185A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | CA2141810A1 Amide derivatives |
| 02/17/1994 | CA2141785A1 Diamino acid derivatives as antihypertensives |
| 02/17/1994 | CA2141588A1 Parathyroid hormone fragments and analogs |
| 02/17/1994 | CA2141557A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 02/17/1994 | CA2141447A1 Conformationally restricted mimetics of reverse turns and peptides containing the same |
| 02/17/1994 | CA2140440A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
| 02/17/1994 | CA2140009A1 Benzodiazepine derivatives |
| 02/17/1994 | CA2125477A1 Therapeutic methods using caesium ions |
| 02/17/1994 | CA2120498A1 Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them |
| 02/17/1994 | CA2119873A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enyzme for its preparation |
| 02/16/1994 | EP0583074A2 Angiotensin converting enzyme inhibitor and method for preparing same |
| 02/16/1994 | EP0583050A2 Recombinant stimulating factor of the neu receptor |
| 02/16/1994 | EP0582916A1 N-methansulfonyl-2-(3-isobutyl-3-(quinol-2-yl-methoxy)-phenyl)-2-cycloalkylacetamides, process for their preparation and their pharmaceutical use |
| 02/16/1994 | EP0582908A1 2-Substituted guinolylmethoxy-phenylacetic acid derivatives, process for their preparation and their pharmaceutical use |
| 02/16/1994 | EP0582665A1 Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |
| 02/16/1994 | EP0582630A1 N?6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body |
| 02/16/1994 | EP0582581A1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO 4,5-c]QUINOLIN-4-AMINES |
| 02/16/1994 | CN1082045A Imidazopyridines |
| 02/16/1994 | CN1082044A 吲哚衍生物 Indole derivatives |
| 02/16/1994 | CN1082041A Imidazolyl-substituted phenylpropionic acid cinnamic acid derivatives |
| 02/16/1994 | CN1082039A Indoles |
| 02/16/1994 | CN1082035A Inhibitors of hiv protease useful for the treatment of aids |